MEDINFAR Competitors and Similar CompaniesClear all

MEDINFAR's competitors and similar companies include Quantum Pharmaceutical, Zydus Lifesciences, Zhejiang Jiuzhou Pharmaceutical and Aoxing Pharmaceutical.

	MEDINFAR MEDINFAR manufacture of pharmaceutical products.	Quantum Pharmaceutical Quantum Pharmaceutical is a manufacturer and supplier of unlicensed medicines and hard-to-source products.	Zydus Lifesciences Zydus Lifesciences (formerly known as Cadila Healthcare) is a company that provides healthcare solutions.	Zhejiang Jiuzhou Pharmaceutical Zhejiang Jiuzhou Pharmaceutical (浙江九洲药业股份有限公司) is a manufacturer and supplier of pharmaceutical products.	Aoxing Pharmaceutical Aoxing Pharmaceutical is a specialty pharmaceutical company.
Founding Date	Founding Date 1970	Founding Date 2004	Founding Date 1952	Founding Date 1973	Founding Date 2002
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Venda Nova, PT HQ Lisboa, PT	Locations Hobson, GB HQ	Locations Ahmedabad, IN HQ Rio De Janeiro, BR Nanterre, FR Ahmedabad, IN Ambernath, IN Ankleshwar, IN Bengaluru, IN see more	Locations Taizhou, CN HQ	Locations Shijiazhuang Shi, CN HQ Shijiazhuang Shi, CN Foster City, US
Employees	Employees 404	Employees 4548% increase	Employees 27,9176% increase	Employees 5,001	Employees 346
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.9 b	Valuation ($) 5.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £76.1m (FY, 2018)	Revenue (est.) ₹267.2b (FY, 2026)	Revenue (est.) ¥5.3b (FY, 2025)	Revenue (est.) $32.3m (FY, 2016)
Cost of goods	Cost of goods N/A	Cost of goods £54.5m (FY, 2018)	Cost of goods ₹72.9b (FY, 2026)	Cost of goods ¥3.5b (FY, 2025)	Cost of goods $7.8m (FY, 2016)
Gross profit	Gross profit N/A	Gross profit £21.6m (FY, 2018)	Gross profit ₹203.7b (FY, 2026)	Gross profit ¥2b (FY, 2025)	Gross profit $24.6m (FY, 2016)
Net income	Net income N/A	Net income (£8.3m) (FY, 2018)	Net income ₹50.3b (FY, 2026)	Net income ¥728.5m (FY, 2025)	Net income $2.1m (FY, 2016)